Elevated level of lysophosphatidic acid among patients with HNF1B mutations and its role in RCAD syndrome: a multiomic study.
Beata MalachowskaJustyna JanikiewiczKarolina PietrowskaKrystyna WykaJoanna MadzioKamila WypyszczakMarcin TkaczykSławomir ChrulRafał ZwiechAnna HogendorfMaciej T MałeckiMaciej BorowiecAdam Jacek KretowskiWojciech MłynarskiAgnieszka DobrzyńMichal CiborowskiWojciech FendlerPublished in: Metabolomics : Official journal of the Metabolomic Society (2022)
LPA is elevated in sera of patients with HNF1Bmut. LPA contributes to the pathogenesis of HNF1B-MODY by affecting Wnt/GSK-3 signaling.